Wang X - Search Results

1

Irinotecan plus fluorouracil-based regimen as second or third-line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma.

Wang X, Wang X, Huang J. Wang X, et al. Thorac Cancer. 2016 Mar;7(2):246-50. doi: 10.1111/1759-7714.12323. Epub 2015 Nov 25. Thorac Cancer. 2016. PMID: 27042229 Free PMC article.

2

SHR-1316, an anti-PD-L1 antibody, plus chemotherapy as the first-line treatment for advanced esophageal squamous cell carcinoma: A multicentre, phase 2 study.

Mu L, Song Y, Zhao K, Liu Y, Fan Q, Wang X, Li Q, Wang X, Huang J. Mu L, et al. Among authors: wang x. Thorac Cancer. 2021 May;12(9):1373-1381. doi: 10.1111/1759-7714.13913. Epub 2021 Mar 24. Thorac Cancer. 2021. PMID: 33760397 Free PMC article. Clinical Trial.

3

Prognostic and predictive impact of neutrophil-to-lymphocyte ratio and HLA-I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy.

Wang L, Zhu Y, Zhang B, Wang X, Mo H, Jiao Y, Xu J, Huang J. Wang L, et al. Among authors: wang x. Thorac Cancer. 2022 Jun;13(11):1631-1641. doi: 10.1111/1759-7714.14431. Epub 2022 Apr 18. Thorac Cancer. 2022. PMID: 35437954 Free PMC article.

4

Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody.

Wang X, Zhang B, Chen X, Mo H, Wu D, Lan B, Li Q, Xu B, Huang J. Wang X, et al. Thorac Cancer. 2019 Jun;10(6):1395-1401. doi: 10.1111/1759-7714.13083. Epub 2019 Apr 24. Thorac Cancer. 2019. PMID: 31017739 Free PMC article. Clinical Trial.

5

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.

Zhang B, Qi L, Wang X, Xu J, Liu Y, Mu L, Wang X, Bai L, Huang J. Zhang B, et al. Among authors: wang x. Cancer Commun (Lond). 2020 Dec;40(12):711-720. doi: 10.1002/cac2.12119. Epub 2020 Dec 12. Cancer Commun (Lond). 2020. PMID: 33314747 Free PMC article. Clinical Trial.

6

Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma.

Wang X, Niu H, Fan Q, Lu P, Ma C, Liu W, Liu Y, Li W, Hu S, Ling Y, Guo L, Ying J, Huang J. Wang X, et al. Oncotarget. 2016 Apr 26;7(17):24744-51. doi: 10.18632/oncotarget.8271. Oncotarget. 2016. PMID: 27013591 Free PMC article.

7

Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study.

Mo H, Huang J, Xu J, Chen X, Wu D, Qu D, Wang X, Lan B, Wang X, Xu J, Zhang H, Chi Y, Yang Q, Xu B. Mo H, et al. Among authors: wang x. Br J Cancer. 2018 Aug;119(5):538-545. doi: 10.1038/s41416-018-0100-3. Epub 2018 May 14. Br J Cancer. 2018. PMID: 29755117 Free PMC article. Clinical Trial.

8

Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China.

Huang J, Mo H, Zhang W, Chen X, Qu D, Wang X, Wu D, Wang X, Lan B, Yang B, Wang P, Zhang B, Yang Q, Jiao Y, Xu B. Huang J, et al. Among authors: wang x, wang p. Cancer. 2019 Mar 1;125(5):742-749. doi: 10.1002/cncr.31855. Epub 2018 Dec 3. Cancer. 2019. PMID: 30508306 Free article. Clinical Trial.

9

Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial.

Huang J, Xu B, Liu Y, Huang J, Lu P, Ba Y, Wu L, Bai Y, Zhang S, Feng J, Cheng Y, Li J, Wen L, Yuan X, Ma C, Hu C, Fan Q, Wang X. Huang J, et al. Among authors: wang x. Cancer Commun (Lond). 2019 Apr 2;39(1):16. doi: 10.1186/s40880-019-0359-7. Cancer Commun (Lond). 2019. PMID: 30940189 Free PMC article. Clinical Trial.

10

Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210.

Chen X, Ma L, Wang X, Mo H, Wu D, Lan B, Qu D, Zhang H, Huang J, Xu B. Chen X, et al. Among authors: wang x. Cancer Biol Med. 2019 Feb;16(1):173-181. doi: 10.20892/j.issn.2095-3941.2018.0172. Cancer Biol Med. 2019. PMID: 31119058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211,574 results

Search Page

Filters